These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4078713)

  • 1. Effect of cyclodextrins on sparingly soluble salts.
    Hirsch W; Fried V; Altman L
    J Pharm Sci; 1985 Oct; 74(10):1123-5. PubMed ID: 4078713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved competitive indicator methods for the study of alpha-cyclodextrin complexes.
    Pendergast DD; Connors KA
    J Pharm Sci; 1984 Dec; 73(12):1779-83. PubMed ID: 6527255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of cyclodextrin inclusion complexes: II--Inclusion complexes between alpha-cyclodextrin and N-desmethyldiazepam and chlordiazepoxide.
    Aboutaleb AE; Abdel Rahman A; Samy EM
    J Pharm Belg; 1988; 43(6):437-44. PubMed ID: 3150006
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
    Vincieri FF; Mazzi G; Papini P; Gelsomini N
    Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
    [No Abstract]   [Full Text] [Related]  

  • 7. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
    Green AR; Guillory JK
    J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexation of several drugs with water-soluble cyclodextrin polymer.
    Szeman J; Ueda H; Szejtli J; Fenyvesi E; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):282-8. PubMed ID: 3594657
    [No Abstract]   [Full Text] [Related]  

  • 10. Complex formation between alpha-cyclodextrin and 4-substituted phenols studied by potentiometric and competitive spectrophotometric methods.
    Lin SF; Connors KA
    J Pharm Sci; 1983 Nov; 72(11):1333-8. PubMed ID: 6644598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex.
    Djedaïni F; Lin SZ; Perly B; Wouessidjewe D
    J Pharm Sci; 1990 Jul; 79(7):643-6. PubMed ID: 2398475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of water structure on cyclodextrin inclusion and light sensitivity of epinephrine].
    Hüttenrauch R; Fricke S; Knop M
    Pharmazie; 1985 Mar; 40(3):199-200. PubMed ID: 4023038
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of beta-cyclodextrin with bile salts in aqueous solutions.
    Miyajima K; Yokoi M; Komatsu H; Nakagaki M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1395-8. PubMed ID: 3731354
    [No Abstract]   [Full Text] [Related]  

  • 16. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of products containing mebendazole and beta-cyclodextrin.
    Kata M; Papp L
    Pharmazie; 1987 Jan; 42(1):65-6. PubMed ID: 3575409
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 19. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

  • 20. Spectral displacement techniques for studying the binding of spectroscopically transparent ligands to cyclodextrins.
    Selvidge LA; Eftink MR
    Anal Biochem; 1986 May; 154(2):400-8. PubMed ID: 3755301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.